CY1118659T1 - Πολυλειτουργικα αλληλομορφα - Google Patents
Πολυλειτουργικα αλληλομορφαInfo
- Publication number
- CY1118659T1 CY1118659T1 CY20171100118T CY171100118T CY1118659T1 CY 1118659 T1 CY1118659 T1 CY 1118659T1 CY 20171100118 T CY20171100118 T CY 20171100118T CY 171100118 T CY171100118 T CY 171100118T CY 1118659 T1 CY1118659 T1 CY 1118659T1
- Authority
- CY
- Cyprus
- Prior art keywords
- allele
- coin
- alleles
- recombinase
- controlled
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/60—Vectors containing traps for, e.g. exons, promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25607809P | 2009-10-29 | 2009-10-29 | |
| PCT/US2010/054654 WO2011059799A1 (en) | 2009-10-29 | 2010-10-29 | Multifunctional alleles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118659T1 true CY1118659T1 (el) | 2017-07-12 |
Family
ID=43244777
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100118T CY1118659T1 (el) | 2009-10-29 | 2017-01-26 | Πολυλειτουργικα αλληλομορφα |
| CY20191100345T CY1121457T1 (el) | 2009-10-29 | 2019-03-26 | Πολυλειτουργικα αλληλομορφα |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100345T CY1121457T1 (el) | 2009-10-29 | 2019-03-26 | Πολυλειτουργικα αλληλομορφα |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20110104799A1 (enExample) |
| EP (2) | EP3147362B1 (enExample) |
| JP (3) | JP5908405B2 (enExample) |
| CN (2) | CN102666854B (enExample) |
| AU (1) | AU2010319894B2 (enExample) |
| CA (1) | CA2779858C (enExample) |
| CY (2) | CY1118659T1 (enExample) |
| DK (2) | DK2494047T3 (enExample) |
| ES (2) | ES2613662T3 (enExample) |
| PL (2) | PL2494047T3 (enExample) |
| PT (2) | PT2494047T (enExample) |
| TR (1) | TR201903376T4 (enExample) |
| WO (1) | WO2011059799A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2494047T (pt) | 2009-10-29 | 2017-02-08 | Regeneron Pharma | Alelos multifuncionais |
| RU2645475C2 (ru) | 2012-04-25 | 2018-02-21 | Регенерон Фармасьютикалз, Инк. | Опосредованное нуклеазой нацеливание с большими нацеливающими векторами |
| US9510569B2 (en) | 2013-03-13 | 2016-12-06 | Regeneron Pharmaceuticals, Inc. | Genetically modified mouse with an inducible Acvr1 gene with a mutant R206H exon 5 that has ectopic bone formation |
| DK2986729T3 (en) | 2013-04-16 | 2018-10-29 | Regeneron Pharma | TARGETED MODIFICATION OF ROOT THROUGH |
| EP3178928B1 (en) * | 2013-08-07 | 2020-06-10 | Regeneron Pharmaceuticals, Inc. | Pint knockout mouse exhibiting a premature aging-associated phenotype |
| WO2015088643A1 (en) | 2013-12-11 | 2015-06-18 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for the targeted modification of a genome |
| PT3080279T (pt) | 2013-12-11 | 2018-12-17 | Regeneron Pharma | Métodos e composições para a modificação direcionada de um genoma |
| RU2704283C9 (ru) | 2014-06-06 | 2020-02-07 | Регенерон Фармасьютикалз, Инк. | Способы и композиции для модификации целевого локуса |
| RS60366B1 (sr) | 2014-06-23 | 2020-07-31 | Regeneron Pharma | Sastavljanje dnk posredovano nukleazom |
| PT3161128T (pt) | 2014-06-26 | 2018-11-21 | Regeneron Pharma | Métodos e composições para modificações genéticas alvejadas e métodos de utilização |
| SG11201702309RA (en) | 2014-10-15 | 2017-04-27 | Regeneron Pharma | Methods and compositions for generating or maintaining pluripotent cells |
| CA2968440A1 (en) | 2014-11-21 | 2016-05-26 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for targeted genetic modification using paired guide rnas |
| BR112017013104A2 (en) | 2014-12-19 | 2018-05-15 | Regeneron Pharmaceuticals, Inc. | methods for modifying a target genomic locus in a cell, for enhancing homologous recombination at a target genomic locus in a cell, and for producing an f0 generation from a nonhuman animal. |
| AU2016233250C1 (en) | 2015-03-16 | 2022-08-18 | Regeneron Pharmaceuticals, Inc. | Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception |
| WO2017180669A1 (en) * | 2016-04-11 | 2017-10-19 | Applied Stemcell, Inc. | Site-specific integration of transgenes |
| US20170332610A1 (en) | 2016-05-20 | 2017-11-23 | Regeneron Pharmaceuticals, Inc. | Methods for breaking immunological tolerance using multiple guide rnas |
| KR20190041476A (ko) | 2016-07-29 | 2019-04-22 | 리제너론 파마슈티칼스 인코포레이티드 | C-절단된 피브릴린-1의 발현을 유도하는 돌연변이를 포함하는 마우스 |
| CN107779462B (zh) * | 2016-08-29 | 2021-06-04 | 中国科学院分子细胞科学卓越创新中心 | 双同源重组谱系示踪技术 |
| WO2018096356A1 (en) * | 2016-11-28 | 2018-05-31 | Horizon Discovery Limited | Methods for conditional gene knock-out |
| SG11201906735RA (en) | 2017-01-23 | 2019-08-27 | Regeneron Pharma | Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof |
| EP4484562A3 (en) | 2017-06-27 | 2025-03-26 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized asgr1 locus |
| JP7139419B2 (ja) | 2017-09-29 | 2022-09-20 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化ｔｔｒ遺伝子座を含む非ヒト動物および使用方法 |
| ES2911249T3 (es) | 2017-11-10 | 2022-05-18 | Regeneron Pharma | Animales no humanos que comprenden una mutación de slc30a8 y métodos de uso |
| IL274740B2 (en) | 2017-11-30 | 2024-06-01 | Regeneron Pharma | Non-human animals comprising a humanized trkb locus |
| US11419319B2 (en) | 2018-06-13 | 2022-08-23 | Regeneran Pharmaceuticals, Inc. | Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that causes ectopic bone formation |
| US11690362B2 (en) | 2018-12-20 | 2023-07-04 | Regeneran Pharmaceuticals, Inc. | Nuclease-mediated repeat expansion |
| JP7524214B2 (ja) | 2019-04-03 | 2024-07-29 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 抗体コード配列をセーフハーバー遺伝子座に挿入するための方法および組成物 |
| ES2966625T3 (es) | 2019-04-04 | 2024-04-23 | Regeneron Pharma | Roedores que comprenden un locus del factor de coagulación 12 humanizado |
| US11891618B2 (en) | 2019-06-04 | 2024-02-06 | Regeneron Pharmaceuticals, Inc. | Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use |
| CA3137764A1 (en) | 2019-06-07 | 2020-12-10 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized albumin locus |
| BR112021025425A2 (pt) * | 2019-06-19 | 2022-02-01 | Hoffmann La Roche | Método para produzir uma célula de mamífero recombinante e uso de mrna de recombinase cre |
| JP7756639B2 (ja) | 2019-11-08 | 2025-10-20 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｘ連鎖性若年網膜分離療法のためのｃｒｉｓｐｒおよびａａｖ戦略 |
| WO2021108363A1 (en) | 2019-11-25 | 2021-06-03 | Regeneron Pharmaceuticals, Inc. | Crispr/cas-mediated upregulation of humanized ttr allele |
| CN115175559A (zh) | 2020-01-28 | 2022-10-11 | 瑞泽恩制药公司 | 包含人源化pnpla3基因座的非人动物及其使用方法 |
| WO2021158883A1 (en) | 2020-02-07 | 2021-08-12 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized klkb1 locus and methods of use |
| EP4125348A1 (en) | 2020-03-23 | 2023-02-08 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use |
| US20230232796A1 (en) | 2020-06-26 | 2023-07-27 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized ace2 locus |
| MX2023007012A (es) | 2020-12-14 | 2023-06-27 | Regeneron Pharma | Metodos para tratar los trastornos metabolicos y las enfermedades cardiovasculares con inhibidores de la subunidad beta e de la inhibina (inhbe). |
| EP4422661A1 (en) | 2021-10-26 | 2024-09-04 | Regeneron Pharmaceuticals, Inc. | Overexpression of lemd2, lemd3, or chmp7 as a therapeutic modality for tauopathy |
| JP2024540086A (ja) | 2021-10-28 | 2024-10-31 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｃ５をノックアウトするためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
| US12582104B2 (en) | 2021-12-08 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Mutant myocilin disease model and uses thereof |
| EP4451863A1 (en) | 2021-12-20 | 2024-10-30 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising humanized ace2 and tmprss loci |
| EP4475671A1 (en) | 2022-02-07 | 2024-12-18 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for defining optimal treatment timeframes in lysosomal disease |
| EP4522726A1 (en) | 2022-05-09 | 2025-03-19 | Regeneron Pharmaceuticals, Inc. | Vectors and methods for in vivo antibody production |
| WO2023220697A1 (en) * | 2022-05-12 | 2023-11-16 | Memorial Sloan-Kettering Cancer Center | Inducible recombinase systems |
| WO2023235725A2 (en) | 2022-05-31 | 2023-12-07 | Regeneron Pharmaceuticals, Inc. | Crispr-based therapeutics for c9orf72 repeat expansion disease |
| JP7635182B2 (ja) * | 2022-08-04 | 2025-02-25 | 株式会社豊田中央研究所 | 相同組換え方法 |
| KR20250044256A (ko) | 2022-08-05 | 2025-03-31 | 리제너론 파마슈티칼스 인코포레이티드 | Tdp-43의 응집 저항성 변이체 |
| WO2024163650A1 (en) | 2023-02-01 | 2024-08-08 | Regeneron Pharmaceuticals, Inc. | Animals comprising a modified klhdc7b locus |
| AU2024285988A1 (en) | 2023-06-08 | 2025-11-20 | Regeneron Pharmaceuticals, Inc. | Animal model with rapid onset of alzheimer's amyloid beta plaque pathology |
| WO2025235388A1 (en) | 2024-05-06 | 2025-11-13 | Regeneron Pharmaceuticals, Inc. | Transgene genomic identification by nuclease-mediated long read sequencing |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1092768A1 (en) * | 1999-10-16 | 2001-04-18 | ARTEMIS Pharmaceuticals GmbH | Conditional gene trapping construct for the disruption of genes |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2002040685A2 (en) * | 2000-11-16 | 2002-05-23 | Cornell Research Foundation, Inc. | Vectors for conditional gene inactivation |
| US7074611B2 (en) | 2001-04-27 | 2006-07-11 | Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie) | Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof |
| US7473557B2 (en) | 2001-06-06 | 2009-01-06 | Regeneron Pharmaceuticals, Inc. | Method for targeting transcriptionally active loci |
| US7205148B2 (en) | 2003-06-11 | 2007-04-17 | Regeneron Pharmaceuticals, Inc. | Genome mutation by intron insertion into an embryonic stem cell genome |
| US7582741B2 (en) * | 2004-07-26 | 2009-09-01 | University Of Massachusetts | Conditional disruption of dicer1 in cell lines and non-human mammals |
| EP1815001B8 (en) | 2004-11-26 | 2011-03-23 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Gene trap cassettes for random and targeted conditional gene inactivation |
| EP1662005A1 (en) * | 2004-11-26 | 2006-05-31 | FrankGen Biotechnologie AG | Enhancer-containing gene trap vectors for random and targeted gene trapping |
| PT2494047T (pt) | 2009-10-29 | 2017-02-08 | Regeneron Pharma | Alelos multifuncionais |
-
2010
- 2010-10-29 PT PT107743916T patent/PT2494047T/pt unknown
- 2010-10-29 CN CN201080056458.9A patent/CN102666854B/zh active Active
- 2010-10-29 PT PT16196614T patent/PT3147362T/pt unknown
- 2010-10-29 JP JP2012537099A patent/JP5908405B2/ja active Active
- 2010-10-29 US US12/915,447 patent/US20110104799A1/en not_active Abandoned
- 2010-10-29 AU AU2010319894A patent/AU2010319894B2/en active Active
- 2010-10-29 CN CN201610565668.XA patent/CN106191126B/zh active Active
- 2010-10-29 CA CA2779858A patent/CA2779858C/en active Active
- 2010-10-29 TR TR2019/03376T patent/TR201903376T4/tr unknown
- 2010-10-29 ES ES10774391.6T patent/ES2613662T3/es active Active
- 2010-10-29 PL PL10774391T patent/PL2494047T3/pl unknown
- 2010-10-29 ES ES16196614T patent/ES2716981T3/es active Active
- 2010-10-29 EP EP16196614.8A patent/EP3147362B1/en active Active
- 2010-10-29 DK DK10774391.6T patent/DK2494047T3/en active
- 2010-10-29 DK DK16196614.8T patent/DK3147362T3/en active
- 2010-10-29 EP EP10774391.6A patent/EP2494047B1/en active Active
- 2010-10-29 PL PL16196614T patent/PL3147362T3/pl unknown
- 2010-10-29 WO PCT/US2010/054654 patent/WO2011059799A1/en not_active Ceased
-
2013
- 2013-07-12 US US13/940,609 patent/US10392633B2/en active Active
-
2016
- 2016-02-01 JP JP2016017198A patent/JP6085696B2/ja active Active
- 2016-07-28 JP JP2016148272A patent/JP6333316B2/ja active Active
-
2017
- 2017-01-26 CY CY20171100118T patent/CY1118659T1/el unknown
-
2019
- 2019-03-26 CY CY20191100345T patent/CY1121457T1/el unknown
- 2019-07-01 US US16/459,236 patent/US11319557B2/en active Active
-
2022
- 2022-04-01 US US17/712,003 patent/US12473574B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121457T1 (el) | Πολυλειτουργικα αλληλομορφα | |
| CY1123973T1 (el) | Συνθεσεις και μεθοδοι για ακριβη ταυτοποιηση μεταλλαξεων | |
| CY1114483T1 (el) | Νεα ρυθμιστικα στοιχεια | |
| CY1125029T1 (el) | Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων | |
| WO2015191780A3 (en) | Ccctc-binding factor (ctcf) rna interactome | |
| CY1126044T1 (el) | Πυραζολο[1,5-αλφα]πυριμιδινες χρησιμες ως αναστολεις της κινασης atr για την αντιμετωπιση καρκινικων νοσων | |
| CY1119484T1 (el) | Dbait και χρησεις αυτου | |
| Cook et al. | Small RNAs in germline development | |
| EP4293122A3 (en) | Single cell whole genome libraries for methylation sequencing | |
| CY1119031T1 (el) | Βακτηριακως λαμβανομενα, ανεπαφα μινικυτταρα που συμπεριλαμβανουν ρυθμιστικο rna | |
| WO2015135035A3 (en) | Determining cancer agressiveness, prognosis and responsiveness to treatment | |
| EP4265723A3 (en) | Reagents and methods for molecular barcoding of nucleic acids of single cells | |
| MX2017006670A (es) | Metodos y composiciones para la modificacion genetica dirigida mediante el uso de arn guia combinados. | |
| MX385330B (es) | Regulación transcripcional guiada por ácido ribonucleico. | |
| EP4357457A3 (en) | Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof | |
| WO2013188638A3 (en) | Endoribonucleases and methods of use thereof | |
| MX388127B (es) | Metodos y composiciones para la modificacion dirigida de un genoma. | |
| BR112012033544A2 (pt) | molécula de ácido nucleíco isolada, constructo, vetor, planta, célula vegetal ou semente de planta, métodos, uso e processo | |
| ES2720999T3 (es) | Método y sistema para seleccionar un fármaco sobre la base de la información del daño de proteína individual para prevenir los efectos secundarios de un fármaco | |
| MX2012011774A (es) | Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que codifican los mismos. | |
| BR112017014031A2 (pt) | n-oligossacaril-transferase recombinante, mutante de n-oligossacaril-transferase recombinante, ácido nucleico, célula hospedeira, e, método para produção de um bioconjugado. | |
| WO2014172489A3 (en) | Targeted modification of rat genome | |
| EP2631291A4 (en) | NUCLEIC ACID MOLECULES FOR INDUCING RNA INTERFERENCE AND USES THEREOF | |
| HK1203075A1 (en) | Substituted phosphorothioate nucleotide analogs | |
| MX2020003113A (es) | Sistemas y metodos para secuenciar acido nucleico. |